N6-Benzoyl-2'-fluoro-2'-deoxyadenosine is a chemically modified nucleoside derivative. It features a benzoyl group protecting the exocyclic amine at the N6 position of the adenine base and a fluorine atom at the 2' position of the deoxyribose sugar, replacing the hydroxyl group. This specific modification renders it a crucial synthetic intermediate. Its primary application is in the synthesis of oligonucleotides, particularly for the production of antisense oligonucleotides and other therapeutic nucleic acids. The 2'-fluoro modification enhances the stability of the resulting oligonucleotide against nuclease degradation and can influence its binding affinity to target RNA. The N6-benzoyl group is a standard protecting group used in solid-phase oligonucleotide synthesis via the phosphoramidite method, which is later removed under basic conditions during the final deprotection step. As a protected building block, it is a key raw material in the research and development of novel genetic medicines. It is not typically used as a final active pharmaceutical ingredient (API) itself but is essential for constructing the oligonucleotide chain.